IMPROVED VACCINATION AGAINST INFLUENZA Russian patent published in 2016 - IPC A61K39/145 A61P31/12

Abstract RU 2599496 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to medicine, specifically to immunology, and can be used for inducing cross-protection against at least one heterosubtypic strain of influenza. To induce cross-protection against at least one heterosubtypic strain of influenza in comparison with influenza strains, antigens of which are present in influenza vaccine, influenza vaccine containing and HA and NA is administered. Where vaccine is a virosomal influenza vaccine, which does not contain an auxiliary agent and which is administered intramuscularly at least three times in one year. Group of inventions also relates to a method of inducing cross-protection against influenza H5N1 strain and to a method for influenza vaccination.

EFFECT: use of present group of inventions makes it possible to provide cross-protection due to administration of virosomal seasonal vaccines, which do not contain an auxiliary agent by normal intramuscular administration.

13 cl, 7 ex, 9 dwg

Similar patents RU2599496C2

Title	Year	Author	Number
COMPUTER-OPTIMIZED ANTIGENS WITH WIDE REACTIVITY SPECTRUM FOR INFLUENZA VIRUSES OF H5N1 AND H1N1	2013	Ross, Ted, M. Crevar, Corey J. Carter, Donald M.	RU2639551C2
EXPRESSION VECTOR BASED ON HUMAN ADENOVIRUS SEROTYPE 5 INDUCING CROSS-PROTECTIVE IMMUNITY TO INFLUENZA A SUBTYPE H3 VIRUSES AND PHARMACEUTICAL COMPOSITION BASED ON IT	2023	Lysenko Andrei Aleksandrovich Sedova Elena Sergeevna Alekseeva Svetlana Viktorovna Shcherbinin Dmitrii Nikolaevich Tutykhina Irina Leonidovna Verkhovskaia Liudmila Viktorovna Avdonina Elena Dmitrievna Bandeliuk Alina Sergeevna Viskova Natalia Iurevna Evgrafov Evgenii Valerevich Dovzhenko Nina Aleksandrovna Nikonova Alena Eduardovna Kalugina Irina Alekseevna Evgrafova Elina Alekseevna Shmarov Maksim Mikhailovich Naroditskii Boris Savelevich Logunov Denis Iurevich Gintsburg Aleksandr Leonidovich	RU2814189C1
ATTENUATED GRIPPOSE VECTOR AND MUCOSAL UNIVERSAL GRIPPOSE VACCINE ON ITS BASIS	2016	Egorov Andrej Yurevich Ferko Boris Krokhin Artem Aleksandrovich Romanova Yuliya Romanovna	RU2660562C2
EXPRESSION VECTOR BASED ON HUMAN ADENOVIRUS 5 SEROTYPE, INDUCING CROSS-PROTECTIVE IMMUNITY TO INFLUENZA A VIRUSES OF SUBTYPE H1, AND A PHARMACEUTICAL COMPOSITION BASED ON IT	2023	Lysenko Andrei Aleksandrovich Sedova Elena Sergeevna Alekseeva Svetlana Viktorovna Shcherbinin Dmitrii Nikolaevich Tutykhina Irina Leonidovna Verkhovskaia Liudmila Viktorovna Avdonina Elena Dmitrievna Bandeliuk Alina Sergeevna Viskova Natalia Iurevna Evgrafov Evgenii Valerevich Dovzhenko Nina Aleksandrovna Nikonova Alena Eduardovna Kalugina Irina Alekseevna Evgrafova Elina Alekseevna Shmarov Maksim Mikhajlovich Naroditskij Boris Savelevich Logunov Denis Yurevich Gintsburg Aleksandr Leonidovich	RU2802753C1
FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPs)	2006	Smit Gejl Brajt Rik Pushko Piter Chzhan Tszin'Ju Makhmud Kutub	RU2483751C2
COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR H3N2 VIRUSES	2013	Ross Ted M. Carter Donald M. Crevar Corey J.	RU2653756C2
RECOMBINANT INFLUENZA VIRUS INTENDED FOR THE PREVENTION OF COVID-19 AND INFLUENZA, METHOD OF ITS PRODUCTION AND USE	2022	Sergeeva Mariya Valerevna Elshin Nikita Dmitrievich Romanovskaya-Romanko Ekaterina Andreevna Stukova Marina Anatolevna Lioznov Dmitrij Anatolevich	RU2802058C1
MUCOSAL INFLUENZA VIRUS VACCINE AND METHOD FOR INFLUENZA PREVENTION	2004	Khasegava Khideki Kurata Takesi Sata Tetsutarou Morijama Masami Tamura Sin-Iti Tanimoto Takefumi	RU2390351C2
METHOD TO PRODUCE FLU VIRUS	2008	Zherdil' Katrin Most Katrin Legastelua Izabell' Bjublo Mishel' Le Gro Fransua-Ksav'E	RU2484136C2
VACCINE COMPOSITION FOR USE IN IMMUNO-COMPROMISED POPULATIONS	2013	Arvidsson Khans Maltais Anna-Karin	RU2661408C2

RU 2 599 496 C2

Authors

Rosendal Ramon

Ros Anna

Radoshevich Katarina

Dates

2016-10-10—Published

2013-03-05—Filed